The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses

Journal of Clinical Investigation

Volumn 110, Issue 10, 2002, Pages 1461-1471

  Lee, Lawrence Y ^a   Miyamoto, Yuko J ^b,c   McIntyre, Bradley W ^b   Höök, Magnus ^a   McCrea, Kirk W ^a,d   McDevitt, Damien ^a,e   Brown, Eric L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BACTERIAL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN MAP; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOMYELITIS; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; SURVIVAL; T LYMPHOCYTE;

EID: 0036853885     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216318     Document Type: Article

References (70)

1. Kissane,J.M. 1997. Staphylococcal infections. In Pathology of Infectious Diseases. Vol. I. D.H. Connor, F.W. Chandler, H.J. Schwartz, H.J. Manz, and E.E. Lack, editors. Appleton and Lange. Stamford, Connecticut, USA. 805-816.
2. Lowy, F.D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
3. Rupp, M.E. 1997. Infections of intravascular catheters and vascular devices. In The Staphylococci in Human Disease. K.B. Crossley and G.L. Archer, editors. Churchill Liningstone. New York, New York, USA. 379-399.
4. Tacconelli, E., Tumbarello, M., and Cauda, R. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:2026-2027.
5. Petros, S., et al. 1998. Severe community acquired pneumonia due to Staphylococcus aureus. Intensive Care Med. 24:189.
6. Kim, H.S., Weilbaecher, D.G., Lie, J.T. J.T., and Titus, J.L. 1978. Myocardial abscesses. Am. J. Clin. Pathol. 70:18-23.
7. Hiramatsu, K., Cui, L., Kuroda, M., and Ito, T 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9:486-493.
8. Patti, J.M., Allen, B.L., McGavin, M.J., and Höök, M. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:585-617.
9. Herrmann, M., Suchard, S.J., Boxer, L.A., Waldvogel, F.A., and Lew, P.D. 1991. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect. Immun. 59:279-288.
10. Fujigaki, Y., et al. 1998. Glomerular injury induced by cationic 70-kD staphylococcal protein; specific immune response is not involved in early phase in rats. J. Pathol. 184:436-445.
11. Chhatwal, G.S., Preissner, K.T., Muller-Berghaus, G., and Blobel, H. 1987. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli. Inject. Immun. 55:1878-1883.
12. Jahreis, A., Beckheinrich, P., and Haustein, U.F. 2000. Effects of two novel cationic staphylococcal proteins (NP-tase and p70)and enterotoxin B on 1gE synthesis and interleukin-4 and interferon-gamma production in patients with atopic dermatitis. Br. J. Dermatol. 142:680-687.
13. Jahreis, A., et al. 1995. Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID). Clin. Exp. Immunol. 100:406-411.
14. Hudson, M.C., Ramp, W.K., and Frankenburg, K.P. 1999. Staphylococcus aureus adhesion to bone matrix and bone-associated biomaterials. FEMS Microbiol. Lett. 173:279-284.
15. Lopes, J.D., dos Reis, M., and Brentani, R.R. 1985. Presence of laminin receptors in Staphylococcus aureus. Science. 229:275-277.
16. 2--dependent inhibitory site. J. Biol. Chem. 273:6821-6829.
17. Vercellotti, G.M., et al. 1985. Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am. J. Pathol. 120:13-21.
18. Wann, ER., Gurusiddappa, S., and Höök, M. 2000. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J. Biol. Chem. 275:13863-13871.
19. Kreikemeyer, B., McDevitt, D., and Podbielski, A. 2002. The role of the Map protein in S aureus matrix protein and eukaryotic cell adherence. Int. J. Med. Microbiol. 292:283-295.
20. Chavakis, T., et al. 2002. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat. Med. 8:687-693.
21. Jonsson, K., McDevitt, D., McGavin, M.H., Patti, J.M., and Höök, M. 1995. Staphylococcus aureus expresses a major histocompatibility complex class II analog. J. Biol. Chem. 270:21457-21460.
22. Guillen, C., et al. 2002. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol. 168:3950-3957.
23. Chang, H.R., et al. 2000. Use of pulsed-field gel electrophoresis in the analysis of recurrent Staphylococcus aureus infections in patients on continuous ambulatory peritoneal dialysis. Am. J. Nephrol. 20:463-467.
24. Hartstein, A.I., Mulligan, M.E., Morthland, V.H., and Kwok, R.Y. 1992. Recurrent Staphylococcus aureus bacteremia. J Clin. Microbiol. 30:670-674.
25. Monteil, M., Hobbs, J., and Citron, K. 1987. Selective immunodeficiency affecting staphylococcal response. Lancet. 2:880-883.
26. Shayegani, M., De Courcy, S.J., Jr., and Mudd, S. 1973. Cell-mediated immunity, in mice infected with S. aureus and elicited with specific bacterial antigens. J. Reticuloendothel. Soc. 14:44-51.
27. Easmon, C.S., and Glynn, A.A. 1975. Cell-mediated immune responses in Staphylococcus aureus infections in mice. Immunology. 29:75-85.
28. Ficker, L., Seal, D, and Wright, P. 1989. Staphylococcal infection and the limbus: Study of the cell-mediated immune response. Eye. 3:190-193.
29. Sarai, Y., et al. 1977. Immunological properties in staphylococcal toxic epidermal necrolysis. Dermatologica. 155:315-318.
30. Verbrugh, H.A., et al. 1980. Phagocytic and chemotactic function of polymorphonuclear and mononuclear leucocytes in patients with recurrent staphylococcal infections. Scand. J. Infect. Dis. 12:111-116.
31. Valmin, K., Hallberg, T., and Hedstrom, S.A. 1982. Recurrent Staphylococcal furunculosis lymphocyte subsets and plasma immunoglobulins. Scand. J. Infect. Dis. 14:153-154.
32. Bremell, T., Lange, S., Yacoub, A., Ryden, C., and Tarkowski, A. 1991. Experimental Staphylococcus aureus arthritis in mice. Infect. Immun. 59:2615-2623.
33. Sloane, R., et al. 1991. A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model. FEMS Microbiol. Lett. 62:239-244.
34. Hussain, M., et al. 2002. Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fibroblasts. Infect Immun. 70:2933-2940.
35. Kreiswirth, B.N., et al. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 305:709-712.
36. Duthie, E.S., and Lorenz, L.L. 1952. Staphylococcal coagulase: Mode of action and antigenicity. J. Gen. Microbiol. 6:95-107.
37. Ponnuraj, K., et al. 2002. Crystallization and preliminary x-ray crystallographic analysis of Ace: A collagen-binding MSCRAMM from Enterococcus faecalis. Biochim. Biophys. Acta. 1596:173-176.
38. Kuroda, M., et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 357:1225-1240.
39. Visai, L., et al. 2000. Monoclonal antibodies to CNA, a collagen-binding microbial surface component recognizing adhesive matrix molecules, detach Staphylococcus aureus from a collagen substrate. J. Biol. Chem. 275:39837-39845.
40. Rich, R.L., et al. 1999. Ace is a collagen-binding MSCRAMM from Enterococcus faecalis. J. Biol. Chem. 274:26939-26945.
41. Guo, B.P., Brown, E.L., Dorward, D.W., Rosenberg, L.C., and Höök, M. 1998. Decorin-binding adhesins from Borrelia burgdorferi. Mol. Microbiol. 30:711-723.
42. Maniatis, T., Fritsch, E.F., and Sambrook, J. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. A.3
43. Brown, E.L., Ullrich, S.E., Pride, M., and Kripke, M.L. 2001. The effect of UV irradiation on infection of mice with Borrelia burgdorferi. Photochem. Photobiol. 73:537-544.
44. Brown, E.L., et al. 2001. Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest. 107:845-852.
45. McGavin, M.H., Krajewska-Pietrasik, D., Ryden, C., and Höök, M. 1993. Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect. Immun. 61:2479-2485.
46. Patti, J.M., et al. 1994. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect. Immun. 62:152-161.
47. Switalski, L.M., et al. 1993. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol. Microbiol. 7:99-107.
48. Joh, H.J., House-Pompeo, K., Patti, J.M., Gurusiddappa, S., and Höök, M. 1994. Fibronectin receptors from gram-positive bacteria: Comparison of active sites. Biochemistry. 33:6086-6092.
49. Brown, E.L., et al. 1995. Modulation of immunity to Borrelia burgdorferi by ultraviolet irradiation: Differential effect on Th1 and Th2 immune responses. Eur. J. Immunol. 25:3017-3022.
50. Pride, M.W., et al. 1998. Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice. J. Leukoc. Biol. 63:542-549.
51. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184:39-51.
52. Kharazmi, A. 1991. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. Immunol. Lett. 30:201-205.
53. Martin-Lopez, J.V., et al. 2002. Detection of Staphylococcus aureus clinical isolates harboring the ica gene cluster needed for biofilm establishment. J. Clin. Microbiol. 40:1569-1570.
54. Suzuki, T., et al. 1995. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:477-486.
55. Engele, M., et al. 2002. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J. Immunol. 168:1328-1337.
56. de Diego, J., Punzon, C., Duarte, M., and Fresno, M 1997. Alteration of macrophage function by a Trypanosoma cruzi membrane mucin. J. Immunol. 159:4983-4989.
57. Abraham, S.N., Beachy, E.H., and Simpson, W.A. 1983. Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect. Immun. 41:1261-1268.
58. Akridge, R.E., Oyafuso, L.K., and Reed, S.G. 1994. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153:5782-5789.
59. Donelson, J.E., Hill, K.L., and El-Sayed, N.M. 1998. Multiple mechanisms of immune evasion by African trypanosomes. Mol. Biochem. Parasitol. 91:51-66.
60. Kyes, S., Horrocks, P., and Newbold, C. 2001. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol. 55:673-707.
61. Lawrenz, M.B., et al. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37:3997-4004.
62. Wurzner, R. 1999. Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry. Mol. Immunol. 36:249-260.
63. Farrell, H.E., et al. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:510-514.
64. Boulton, I.C., and Gray-Owen, S.D. 2002. Neisserial binding to CEA-CAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat. Immunol. 3:229-236.
65. Cuff, S., and Ruby, J. 1996. Evasion of apoptosis by DNA viruses. Immunol. Cell Biol. 74:527-537.
66. Das, G., Vohra, H., Saha, B., Agrewala, J.N., and Mishra, G.C. 1998 Leishmania donovani infection of a susceptible host results in apoptosis of Th1-like cells: Rescue of anti-leishmanial CMI by providing Th1-specific bystander costimulation. Microbiol. Immunol. 42:795-801.
67. Monack, D.M., Mecsas, J., Ghori, N., and Falkow, S. 1997. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. USA. 94:10385-10390.
68. Nunes, M.P., Andrade, R.M., Lopes, M.F., and DosReis, G.A. 1998. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts. J. Immunol. 160:1313-1319.
69. Wei, S., et al. 2002. Toxoplasma gondü-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis. Infect. Immun. 70:1750-1760.
70. Tzianabos, A.O., and Kasper, D.L., 2002 Role of T cells in abscess formation. Curr. Opin. Microbiol. 5:92-96.